These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24307574)

  • 1. Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo.
    Ni Z; Knorr DA; Bendzick L; Allred J; Kaufman DS
    Stem Cells; 2014 Apr; 32(4):1021-31. PubMed ID: 24307574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms.
    Ni Z; Knorr DA; Clouser CL; Hexum MK; Southern P; Mansky LM; Park IH; Kaufman DS
    J Virol; 2011 Jan; 85(1):43-50. PubMed ID: 20962093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Improved Method to Produce Clinical-Scale Natural Killer Cells from Human Pluripotent Stem Cells.
    Zhu H; Kaufman DS
    Methods Mol Biol; 2019; 2048():107-119. PubMed ID: 31396935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental dissociation of T cells from B, NK, and myeloid cells revealed by MHC class II-specific chimeric immune receptors bearing TCR-zeta or FcR-gamma chain signaling domains.
    Lin WY; Roberts MR
    Blood; 2002 Oct; 100(8):3045-8. PubMed ID: 12351421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity.
    Li Y; Hermanson DL; Moriarity BS; Kaufman DS
    Cell Stem Cell; 2018 Aug; 23(2):181-192.e5. PubMed ID: 30082067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic expression of anti-HIV-1 shRNAs protects CD8(+) T cells modified with CD4ζ CAR from HIV-1 infection and alleviates impairment of cell proliferation.
    Kamata M; Kim PY; Ng HL; Ringpis GE; Kranz E; Chan J; O'Connor S; Yang OO; Chen IS
    Biochem Biophys Res Commun; 2015 Jul; 463(3):216-21. PubMed ID: 25998390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy.
    Knorr DA; Ni Z; Hermanson D; Hexum MK; Bendzick L; Cooper LJ; Lee DA; Kaufman DS
    Stem Cells Transl Med; 2013 Apr; 2(4):274-83. PubMed ID: 23515118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cells.
    Ueda T; Kumagai A; Iriguchi S; Yasui Y; Miyasaka T; Nakagoshi K; Nakane K; Saito K; Takahashi M; Sasaki A; Yoshida S; Takasu N; Seno H; Uemura Y; Tamada K; Nakatsura T; Kaneko S
    Cancer Sci; 2020 May; 111(5):1478-1490. PubMed ID: 32133731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Natural Killer Cells Differentiated from Various Pluripotent Stem Cells.
    Han J; Son H; Jung D; Kim KY; Jin C; Hwang H; Kang SS; Mitalipov S; An HJ; Lee Y; Kang E
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged survival and tissue trafficking following adoptive transfer of CD4zeta gene-modified autologous CD4(+) and CD8(+) T cells in human immunodeficiency virus-infected subjects.
    Mitsuyasu RT; Anton PA; Deeks SG; Scadden DT; Connick E; Downs MT; Bakker A; Roberts MR; June CH; Jalali S; Lin AA; Pennathur-Das R; Hege KM
    Blood; 2000 Aug; 96(3):785-93. PubMed ID: 10910888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.
    Wang D; Quan Y; Yan Q; Morales JE; Wetsel RA
    Stem Cells Transl Med; 2015 Oct; 4(10):1234-45. PubMed ID: 26285657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of innate immune cells from human pluripotent stem cells.
    Bernareggi D; Pouyanfard S; Kaufman DS
    Exp Hematol; 2019 Mar; 71():13-23. PubMed ID: 30611869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer.
    Hermanson DL; Bendzick L; Pribyl L; McCullar V; Vogel RI; Miller JS; Geller MA; Kaufman DS
    Stem Cells; 2016 Jan; 34(1):93-101. PubMed ID: 26503833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholamban as a crucial determinant of the inotropic response of human pluripotent stem cell-derived ventricular cardiomyocytes and engineered 3-dimensional tissue constructs.
    Chen G; Li S; Karakikes I; Ren L; Chow MZ; Chopra A; Keung W; Yan B; Chan CW; Costa KD; Kong CW; Hajjar RJ; Chen CS; Li RA
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):193-202. PubMed ID: 25504561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, expansion, and in vivo monitoring of human NK cells from human embryonic stem cells (hESCs) and and induced pluripotent stem cells (iPSCs).
    Bock AM; Knorr D; Kaufman DS
    J Vis Exp; 2013 Apr; (74):e50337. PubMed ID: 23644738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
    Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.
    Deeks SG; Wagner B; Anton PA; Mitsuyasu RT; Scadden DT; Huang C; Macken C; Richman DD; Christopherson C; June CH; Lazar R; Broad DF; Jalali S; Hege KM
    Mol Ther; 2002 Jun; 5(6):788-97. PubMed ID: 12027564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted integration of EpCAM-specific CAR in human induced pluripotent stem cells and their differentiation into NK cells.
    Tang SY; Zha S; Du Z; Zeng J; Zhu D; Luo Y; Wang S
    Stem Cell Res Ther; 2021 Nov; 12(1):580. PubMed ID: 34802459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy.
    Zhu H; Kaufman DS
    Blood Sci; 2019 Aug; 1(1):4-11. PubMed ID: 35402797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.
    Chehimi J; Bandyopadhyay S; Prakash K; Perussia B; Hassan NF; Kawashima H; Campbell D; Kornbluth J; Starr SE
    J Virol; 1991 Apr; 65(4):1812-22. PubMed ID: 1672164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.